Senior insider sale
Chief Executive Officer at ITEOS THERAPEUTICS, INC. — senior position signals high conviction
$2.64M
261.41K shares
DETHEUX MICHEL plans to sell 261.41K shares of ITEOS THERAPEUTICS, INC. valued at approximately $2.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/10/2025 | Exercise of Stock Options Cash | 52.28K | — |
| Total | 52.28K | ||
Completed
Units to sell
8.40K
Market value
$84.3K
Units to sell
43.88K
Market value
$440.3K
Units to sell
8.40K
Market value
$85.8K
Units to sell
43.88K
Market value
$448.1K
Units to sell
43.88K
Market value
$445.3K
Units to sell
8.40K
Market value
$85.2K
Units to sell
43.88K
Market value
$443.3K
Units to sell
8.40K
Market value
$84.8K
Planned — Approximate Date
Units to sell
52.28K
Market value
$523.9K
Units
261.41K
Value
$2.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/9/2025 | 8.40K | $84.3K | — | Completed |
6/9/2025 | 43.88K | $440.3K | — | Completed |
6/6/2025 | 8.40K | $85.8K | — | Completed |
6/6/2025 | 43.88K | $448.1K | — | Completed |
6/5/2025 | 43.88K | $445.3K | — | Completed |
6/5/2025 | 8.40K | $85.2K | — | Completed |
6/4/2025 | 43.88K | $443.3K | — | Completed |
6/4/2025 | 8.40K | $84.8K | — | Completed |
| Planned — Approximate Date | ||||
6/10/2025 | 52.28K | $523.9K | Nasdaq | Planned |
| Total | 261.41K | $2.64M | ||